108 related articles for article (PubMed ID: 9894772)
21. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
Kuo JY; Chiang H; Chen KK; Chang LS
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):411-7. PubMed ID: 10418173
[TBL] [Abstract][Full Text] [Related]
22. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
[TBL] [Abstract][Full Text] [Related]
23. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
25. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T
J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
[TBL] [Abstract][Full Text] [Related]
27. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
28. Micrometastasis and expression of nm23 messenger RNA of lymph nodes from lung cancer and the postoperative clinical outcome.
Ayabe T; Tomita M; Matsuzaki Y; Ninomiya H; Hara M; Shimizu T; Edagawa M; Onitsuka T; Hamada M
Ann Thorac Cardiovasc Surg; 2004 Jun; 10(3):152-9. PubMed ID: 15312010
[TBL] [Abstract][Full Text] [Related]
29. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.
Tang Z; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S
Chin Med J (Engl); 1998 Apr; 111(4):313-8. PubMed ID: 10374394
[TBL] [Abstract][Full Text] [Related]
30. nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia.
Koomägi R; Sauerbrey A; Zintl F; Volm M
Anticancer Res; 1998; 18(6A):4307-9. PubMed ID: 9891483
[TBL] [Abstract][Full Text] [Related]
31. [Expression of nm23-H1 gene in oral squamous cell carcinoma and its relation to tumor metastasis].
Zhang T; Lai Q; Du D; Zhao Y; Chai J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):19-24. PubMed ID: 12569635
[TBL] [Abstract][Full Text] [Related]
32. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
33. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
[TBL] [Abstract][Full Text] [Related]
34. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
Kuo JY; Chang KM; Chen KK; Chang LS
Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
[TBL] [Abstract][Full Text] [Related]
35. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis].
Zhang T; Lai Q; Du D
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896
[TBL] [Abstract][Full Text] [Related]
36. Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer.
Sgouros J; Galani E; Gonos E; Moutsatsou P; Belechri M; Skarlos D; Dionyssiou-Asteriou A
In Vivo; 2007; 21(3):519-22. PubMed ID: 17591363
[TBL] [Abstract][Full Text] [Related]
37. Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma.
Roymans D; Willems R; Vissenberg K; De Jonghe C; Grobben B; Claes P; Lascu I; Van Bockstaele D; Verbelen JP; Van Broeckhoven C; Slegers H
Exp Cell Res; 2000 Nov; 261(1):127-38. PubMed ID: 11082283
[TBL] [Abstract][Full Text] [Related]
38. [Angiogenesis and the expression of nm23-H(1) tumor metastatic suppressor gene in primary breast carcinoma and their relations to lymph node metastasis].
Li Y; Wu F; Gong W
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):177-9. PubMed ID: 11955409
[TBL] [Abstract][Full Text] [Related]
39. Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV.
Valentijn LJ; Koster J; Versteeg R
Genomics; 2006 Apr; 87(4):483-9. PubMed ID: 16442775
[TBL] [Abstract][Full Text] [Related]
40. [Northern blot analysis of nm23 gene expression in human lung cancer].
Liu L; Qin Y; Zhou Q
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):342-4. PubMed ID: 10921026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
